Treatment outcomes refer to all TB cases who were notified in a specified period that were either started treatment and those did not start treatment due to various reasons. The expected outcomes are cured, treatment completed, failure, lost to follow up and death. The DS-TB and DR-TB patient outcomes are evaluated separately due difference in treatment period and regimens.
TB Treatment success rate of new and relapse DS-TB
TB treatment success rate remained at 90% for three consecutive years (2015-2017), then increased gradually to 96% from 2018 to 2022. The increase might have been contributed improvement in treatment adherence support from community health workers and health care workers at health facilities and reliable availability of TB medicines in health facilities. Figure 7 shows trends of treatment success rate among drug susceptible new and relapse TB patients.
Figure 6: TB Treatment success rate, new and relapse (Source: DHIS2-ETL)
TB Treatment success rate, by region
The country targeted to successfully treat more than 90% of TB patients notified in 2022. As shown in figure 8 below, all regions have achieved the national target as they performed above 90%. Kagera regions has treatment success rate of 99%, followed by Dodoma, Simiyu, Ruvuma and Kilimanjaro all with 98% TB treatment success rate.
Figure 7:Treatment success rate, new and relapse by region (Source: DHIS2 ETL)